Skip to content

Senior Centers, Nursing Homes, Adult Day Care

Narrow screen resolution Wide screen resolution Auto adjust screen size Increase font size Decrease font size Default font size
Financial & Legal
Arthritis / Rheumatology News From Medical News Today
Latest Arthritis / Rheumatology News From Medical News Today.

  • Cartilage Repair Gel Under Development, Which Will Improve Quality Of Life For People Suffering With Medical Joint Trouble
    The University of Bradford's School of Engineering, Design and Technology and Advanced Gel Technology Ltd (AGT), a University spin-out company, are developing a cartilage repair gel to improve the quality of life for people suffering with medical joint trouble such as osteoarthritis.

  • New Guidelines For Treating Rheumatoid Arthritis
    Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB). Lead author Kenneth Saag, M.D., M.Sc.

  • Roche Comment On NICE Anti-TNF Inhibitor Sequencing FAD
    Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they will continue to benefit from access to effective treatment with MabThera (rituximab), following the use of one anti-TNF, for this debilitating disease.

  • Study Showed Half Of Patients Treated With Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission
    Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Amgen (NASDAQ:AMGN) announced the publication of data from the COMET (COmbination of Methotrexate and ETanercept in Active Early Rheumatoid Arthritis) trial demonstrating that half of patients treated with the combination of ENBREL and methotrexate achieved Disease Activity Score (DAS) clinical remission and nearly all had no progression of joint damage.

  • Improved Rheumatoid Arthritis Remission With Combined Therapy
    For patients with active, early stage, moderate-to-severe rheumatoid arthritis, a combination treatment with methotrexate and etanercept can improve remission and radiographic non-progression rates within one year in comparison with just methotrexate. Additionally, more patients are also able to remain employed. These conclusions are published in an article released early Online on July 16, 2008 in The Lancet.

  • Custom-Made Insoles Offer Relief To Sufferers Of Foot Pain
    Custom-made insoles known as foot orthoses can reduce foot pain caused by arthritis, overly prominent big toe joints and highly arched feet, a new systematic review shows. A team of Cochrane Researchers found that custom orthoses were safe interventions for foot pain in a number of different conditions. However, more research is required to develop an in depth understanding of their effectiveness.

  • Greater Relief From Osteoarthritis Symptoms Found In Joint Replacement Surgery
    The long term health outcomes of hip or knee replacement surgery in older adults are excellent despite taking several weeks to recover, according to a report released on July 14, 2008 in the Archives of Internal Medicine, one of the JAMA/Archives journals. Osteoarthritis is a degenerative joint disease characterized by inflammation caused by damage to the cartilage that cushions them. It causes debilitating pain and can seriously restrict mobility and physical ability.

  • New Survey Findings Reveal Emotional And Physical Toll Of Rheumatoid Arthritis And The Advancement Of Treatment Through "Generations"
    Emotional and physical limitations are significant challenges cited by people diagnosed with rheumatoid arthritis (RA), according to the results released from two new, groundbreaking parallel surveys.

  • Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study For Gout
    Ardea Biosciences, Inc. (Nasdaq: RDEA) announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patients with hyperuricemia. Gout, also known as metabolic arthritis, is a painful and debilitating disease caused by abnormally elevated levels of uric acid in the blood stream, and is the most common form of inflammatory arthritis in men over 40. The Company also announced that gout specialist, Dr.

  • Tilapia Contains Potentially Dangerous Fatty Acid Combination
    Farm-raised tilapia, one of the most highly consumed fish in America, has very low levels of beneficial omega-3 fatty acids and, perhaps worse, very high levels of omega-6 fatty acids, according to new research from Wake Forest University School of Medicine.


pickin_and_grinnin_8.jpg